Annual Grant Award Dollars
| Investigator | Title | Sponsor | ID | Dates | Amount |
| John Paul Clancy, MD | CFF-TDN site | Cystic Fibrosis Fdn Therapeutics, Inc | AMIN09Y0/CLANCY14Y0 | 01/01/2013 - 12/31/2017 | $112,468 |
| Jason C Woods, PhD | Severe Asthma Research Program | National Institutes of Health (Washington University) | U10 HL109257 | 02/01/2013 - 05/31/2017 | $8,547 |
| Michael Seid, PhD | FL3X: An Adaptive Intervention to Improve Outcomes for Youth with Type 1 Diabetes | National Institutes of Health (University of North Carolina) | UC4 DK101132 | 09/15/2013 - 06/30/2018 | $600,736 |
| Anjaparavanda Naren, PhD | Inhibition of an Apical cAMP/cGMP Transporter (MRP4) in the Gut Induces Diarrhea | National Institutes of Health | R01 DK080834 | 09/18/2013 - 03/31/2018 | $333,313 |
| Anjaparavanda Naren, PhD | Characterization of an Inhibitory Protein Complex for Cystic Fibrosis Therapy | National Institutes of Health (Univ of Tennessee Health Science Center) | R01 HL123535 | 08/15/2014 - 06/30/2019 | $17,539 |
| Gary McPhail, MD | Cystic Fibrosis Center Program Accreditation And Funding | Cystic Fibrosis Foundation | CC160-130 | 07/01/2013 - 06/30/2018 | $150,270 |
| Michael Seid, PhD | Measures of Hypoglycemia and Glycemic Variability Using Continuous Glucose Monitoring in the FL3X Intervention for Youth With Type 1 Diabetes | The Leona M & Harry B Helmsley Charitabl (University of North Carolina) | 2014PG-T1D030 | 01/01/2014 - 12/31/2017 | $8,100 |
| John Paul Clancy, MD | Pilot Development of Translational Primary Human Airway Model Systems to Advance CF Care | Cystic Fibrosis Foundation | CLANCY14XX0 | 07/01/2014 - 06/30/2018 | $95,794 |
| Anjaparavanda Naren, PhD | CF-Patient Specific Enteroids from Small Intestine and Colon | Cystic Fibrosis Fdn Therapeutics, Inc | NAREN14XX0 | 07/01/2014 - 06/30/2018 | $226,708 |
| Jason C Woods, PhD | Molecular Pathogenesis and Treatment of Pulmonary Alveolar Microlithiasis | National Institutes of Health (University of Cincinnati) | R01 HL127455 | 04/01/2015 - 03/31/2020 | $36,075 |
| John Paul Clancy, MD | PROSPECT | Cystic Fibrosis Fdn Therapeutics, Inc | CLANCY14K1 | 07/01/2014 - 06/30/2019 | $37,047 |
| Anjaparavanda Naren, PhD | LPA2 Receptor-containing Complexes in Regulating Secretory Diarrhea | National Institutes of Health | R01 DK093045 | 07/01/2015 - 06/30/2020 | $351,000 |
| Sara M Zak, MD | First/Second Year Clinical Fellowship Grant Application | Cystic Fibrosis Foundation | ZAK15B0 | 07/01/2015 - 06/30/2017 | $66,250 |
| Raouf Samy Amin, MD | Impact of Treatment of Mild Sleep-Disordered Breathing on Children’s Health-CCC | National Institutes of Health (Children's Hospital of Philadelphia) | U01 HL125295 | 09/04/2015 - 10/31/2016 | $239,150 |
| John Paul Clancy, MD | TDC ARC Award | Cystic Fibrosis Fdn Therapeutics, Inc | CLANCY14Y4 | 12/01/2014 - 11/30/2018 | $32,694 |
| Zackary Cleveland, PhD | Time-Resolved 129Xe Ventilation-Perfusion MRI in Models of Acute Lung Injury | National Institutes of Health | R00 HL111217 | 08/15/2015 - 07/31/2018 | $242,816 |
| William Hardie, MD John Paul Clancy, MD |
Cincinnati Children's Summer Medical Student Respiratory Research Fellowship | National Institutes of Health | T35 HL113229 | 05/01/2016 - 04/30/2021 | $68,526 |
| John Paul Clancy, MD | Personalizing Cystic Fibrosis Research Translation | Cystic Fibrosis Foundation | CLANCY15R0 | 07/01/2015 - 06/30/2019 | $470,000 |
| Gary McPhail, MD | A Two-Part Multicenter Prospective Longitudinal Study of CFTR-Dependent Disease Profiling in Cystic Fibrosis | Cystic Fibrosis Fdn Therapeutics, Inc (Children's Hosp & Reg Med Ct-Seattle) | PROSPECT-OB-14 | 02/23/2015 - 02/22/2018 | $83,492 |
| John Paul Clancy, MD | SHIP (Saline Hypertonic in Preschoolers) Study - Planning Grant | Cystic Fibrosis Fdn Therapeutics, Inc (Children's Hosp & Reg Med Ct-Seattle) | SHIP14K0 | 11/01/2014 - 10/31/2018 | $34,625 |
| Daniel Grossoehme, D.Min. | Training Research-Literate Chaplains as Ambassadors for Spirituality and Health: Phase I | John Templeton Foundation (Rush Medical University Center) | 51996 | 07/01/2015 - 06/30/2019 | $8,826 |
| Jason C Woods, PhD John Paul Clancy, MD |
UTE MRI to Monitor CF Lung Disease and Response to CFTR Modulation in Young Children | National Institutes of Health | R01 HL131012 | 05/01/2016 - 03/31/2021 | $745,633 |
| Anjaparavanda Naren, PhD | Human Small Intestinal Model from CF-Patients using Pluripotent Stem Cells | Cystic Fibrosis Foundation | NAREN16I0 | 04/01/2016 - 03/31/2018 | $54,000 |
| John J Brewington, MD | Sensitivity of Corrected F508del CFTR to Chronic beta-agonist Therapy | Cystic Fibrosis Foundation | BREWIN16A0 | 07/01/2016 - 06/30/2019 | $130,000 |
| Zackary Cleveland, PhD | Regional Biomarkers of Peripheral Lung Disease in Cystic Fibrosis | Cystic Fibrosis Fdn Therapeutics, Inc | CLEVEL16A0 | 04/01/2016 - 03/31/2019 | $108,000 |
| Anjaparavanda Naren, PhD | Transporters and Hematopoietic Toxicity | National Institutes of Health (St Jude's Children's Hospital) | R01 CA194206 | 07/01/2016 - 06/30/2021 | $23,595 |
| Satish K Madala, PhD Anil Goud Jegga, DVM |
Integrative Analysis of Multi-omics Data to Target Fibroblast Activation in IPF | National Institutes of Health | R21 HL133539 | 07/05/2016 - 06/30/2018 | $63,929.50 |
| Michael Seid, PhD | A CF C3N Care Model of the Future: Proposal for Piloting a Learning Health System | Cystic Fibrosis Fdn Therapeutics, Inc | SEID15A0 | 01/01/2016 - 12/31/2018 | $1,542,986 |
| Satish K Madala, PhD | WT1 Regulation of Pulmonary Fibrosis | National Institutes of Health | R01 HL134801 | 05/22/2017 - 04/30/2022 | $409,242 |
| John Paul Clancy, MD | CFFT Biomarker Consortium | Cystic Fibrosis Fdn Therapeutics, Inc | CLANCY11CS0 | 01/01/2016 - 12/31/2017 | $23,230 |
| Assem Ziady, PhD | Manipulating Vector Interactome to Enhance Gene Transfer in Cystic Fibrosis | Cystic Fibrosis Foundation | ZIADY1610 | 11/01/2016 - 10/31/2018 | $54,000 |
| Christopher Siracusa, MD | CFF Success with Therapies Research Consortium | Cystic Fibrosis Fdn Therapeutics, Inc | SIRACU15PE0 | 08/01/2016 - 07/31/2018 | $27,000 |
| Geoffrey Walter Rulong, MD | Custom 3-D Printed Non-invasive Ventilation Mask | American Sleep Medicine Foundation | 160-FP-17 | 02/14/2017 - 02/13/2018 | $19,377 |
| Raouf Samy Amin, MD | Impact of Treatment of Mild Sleep-Disordered Breathing on Children’s Health-CCC | National Institutes of Health (Children's Hospital of Philadelphia) | U01 HL125295 | 07/01/2016 - 06/30/2020 | $250,723 |
| Christopher Siracusa, MD | DESIGN CF: Developing e-Health Systems to Improve Growth and Nutrition in CF | Cystic Fibrosis Fdn Therapeutics, Inc (Children's Hospital Boston) | CHB - Siracusa,Chris | 01/01/2017 - 12/31/2017 | $4,190 |
| Theresa Guilbert, MD, MS | Controlling and Preventing Asthma Progression and Severity in Kids (CASK) | National Institutes of Health (Children's Hospital Boston) | U01 AI126614 | 04/01/2017 - 06/30/2017 | $50,000 |
| Total Annual Grant Award Dollars | $6,729,881.50 | ||||
Annual Industry Award Dollars
| Investigator | Industry Sponsor | Amount |
| Anjaparavanda Naren, PhD | Ironwood Pharmaceuticals, Inc. | $200,000 |
| Gary McPhail, MD | Vertex Pharmaceutical Incorporated | $94,211 |
| John Paul Clancy, MD | Concert Pharmaceuticals, Inc | $70,149 |
| Raouf Samy Amin, MD | Vertex Pharmaceutical Incorporated | $15,000 |
| Total Annual Industry Award Dollars | $379,360 | |
